Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram Negative Meningitis”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Testing effectiveness (Phase 2)UnknownNCT02919293
What this trial is testing

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 360
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Not applicableStudy completedNCT03505879
What this trial is testing

Next Generation Sequencing Detection of Lyme Disease

Who this might be right for
Lyme DiseasePediatric Infectious DiseaseErythema Migrans+3 more
Stony Brook University 15
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Testing effectiveness (Phase 2)Study completedNCT01210885
What this trial is testing

Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 495
Post-approval studies (Phase 4)Active Not RecruitingNCT05935176
What this trial is testing

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 660
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Large-scale testing (Phase 3)UnknownNCT05252715
What this trial is testing

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,200
Post-approval studies (Phase 4)Study completedNCT02591290
What this trial is testing

Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 60
Large-scale testing (Phase 3)Study completedNCT01717638
What this trial is testing

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 805
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Testing effectiveness (Phase 2)UnknownNCT00752882
What this trial is testing

Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration

Who this might be right for
Pseudomonas Aeruginosa Meningitis
University Hospital, Clermont-Ferrand 24
Testing effectiveness (Phase 2)Study completedNCT00994695
What this trial is testing

Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine

Who this might be right for
Meningococcal Meningitis
Armauer Hansen Research Institute, Ethiopia 412
Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751
Testing effectiveness (Phase 2)Study completedNCT00808028
What this trial is testing

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Who this might be right for
Meningitis, Meningococcal
Pfizer 538
Testing effectiveness (Phase 2)Study completedNCT01897402
What this trial is testing

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 525
Large-scale testing (Phase 3)Study completedNCT02752906
What this trial is testing

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 810
Post-approval studies (Phase 4)WithdrawnNCT03431675
What this trial is testing

Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

Who this might be right for
Meningitis, Meningococcal
Epicentre
Post-approval studies (Phase 4)Study completedNCT00777257
What this trial is testing

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Who this might be right for
MeningitisMeningococcemiaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,345
Load More Results